Details of the Drug Formulation (DFM)

General Information of DFM (ID: F19974)
Name
Simethicone 125 mg tablet
Company
GlaxoSmithKline
Active Pharmaceutical Ingredient (API) Simethicone API Info click to show the detail info of this API
Irritable bowel syndrome ICD-11: DD91 Approved
Drug Inactive Ingredient (DIGs)
DIG ID DIG Info DIG Name DIG Functional Class
E01VHX DIG Info D&C red no. 30 Colorant
E0NN4I DIG Info Dextrin Binding agent ...
E0M1JK DIG Info Propylene glycol Antimicrobial preservative ...
E01UTV DIG Info Silicon dioxide Anticaking agent ...
Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM
      Oxidoreductase (ORase)
            DBT Name: Albendazole monooxygenase (CYP3A4) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment (1) for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Propylene glycol
                    Biological Activity Inhibition ratio < 20 % (tested by experiment) [1]
                    Tested Species Homo sapiens (Human)
                    UniProt ID CP3A4_HUMAN
               Experiment (2) for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Silicon dioxide
                    Biological Activity Protein expression downregulation (tested by experiment) [2]
                    Tested Species Homo sapiens (Human)
                    UniProt ID CP3A4_HUMAN
      Other protein families (OPF)
            DBT Name: Heat shock factor 1 (HSF1) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG D&C red no. 30
                    Biological Activity EC50 = 9054 nM (estimated based on the structural similarity with CHEMBL1339303 ) [3]
                    Structural Similarity Tanimoto coefficient = 0.776859504
                    Tested Species Mus musculus (Mouse)
                    UniProt ID HSF1_MOUSE
            DBT Name: Nuclear factor-kappa B (NFKB) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG D&C red no. 30
                    Biological Activity EC50 = 122869 nM (estimated based on the structural similarity with CHEMBL1339303 ) [3]
                    Structural Similarity Tanimoto coefficient = 0.776859504
                    Tested Species Homo sapiens (Human)
                    UniProt ID NFKB1_HUMAN ; NFKB2_HUMAN ; TF65_HUMAN
      Cell line (CELL)
            DBT Name: Colon cancer Caco-2 cells (Caco-2) Click to Show/Hide
               Detailed Information DBT Info click to show the detail info of this DBT
               Experiment for Assessing the Biological Activity of the Studied DIG on This DBT
                    Interacting DIG Dextrin
                    Biological Activity Inhibition ratio > 55 % (tested by experiment) [4]
                    Tested Species Homo sapiens (Human)
References
1 Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration. Eur J Pharm Biopharm. 2008 Sep;70(1):279-88.
2 Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells. Pharm Res. 2010 Aug;27(8):1703-12.
3 PubChem BioAssay data set.
4 Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS). Int J Pharm. 2013 Apr 15;447(1-2):192-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.